Cara Therapeutics Stock News

Cara Therapeutics Inc (NASDAQ:CARA) – Equities research analysts at Piper Sandler cut their FY2022 earnings per share estimates for shares of Cara Therapeutics in a report released on Wednesday, Mar

Blueshift Asset Management LLC bought a new position in shares of Cara Therapeutics Inc (NASDAQ:CARA) during the fourth quarter, according to its most recent filing with the Securities and Exchange Co

Cara Therapeutics (NASDAQ:CARA) was upgraded by research analysts at BidaskClub from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday, BidAskClu

Cara Therapeutics (NASDAQ:CARA): despite Covid-19 disruptions, remains on track to report topline data from the Phase 3 KALM-2 study of Korsuva (difelikefalin) in hemodialysis patients with moderate-t

Cara Therapeutics plans to sumbit NDA for KORSUVA injection in 2H20 CARA

Cara Therapeutics expects interim analysis from Phase 2 trial in AD in Q2 CARA

Cara Therapeutics on track to report data from KALM-2 Phase 3 trial in 2Q20 CARA

- On track to report topline data for KALM-2 Phase 3 global trial of  KORSUVA™ Injection in second quarter –                    - On track to complete interim statistical.

Q4 2019 Cara Therapeutics Inc Earnings Call

It's easy to match the overall market return by buying an index fund. Active investors aim to buy stocks that vastly...

Q4 2019 Cara Therapeutics Inc Earnings Call

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) * Biomerica, Inc. (NASDAQ: BMRA) * Centogene NV (

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) Biomerica, Inc. (NASDAQ...

Cara Therapeutics Inc (NASDAQ:CARA) has received a consensus rating of “Buy” from the eight brokerages that are covering the company, Marketbeat Ratings reports. Two investment analysts have rated

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ...